Subtle differences between HER2-low and HER2 0 in terms of TP53 mutations and gene expression have been previously reported and indicate an overall “luminal-like” pattern for HER2-low BC [7, 36, 40]. This evidence concerns the gene ERBB2 and breast cancer.